Royce & Associates’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.8M | Buy |
|
|||||
|
2025
Q1 | $73.8M | Buy |
|
|||||
|
2024
Q4 | $90M | Sell |
|
|||||
|
2024
Q3 | $97.3M | Buy |
|
|||||
|
2024
Q2 | $97.6M | Sell |
|
|||||
|
2024
Q1 | $108M | Buy |
|
|||||
|
2023
Q4 | $82.6M | Buy |
|
|||||
|
2023
Q3 | $84.9M | Buy |
|
|||||
|
2023
Q2 | $77.2M | Buy |
|
|||||
|
2023
Q1 | $69.8M | Buy |
|
|||||
|
2022
Q4 | $64.9M | Sell |
|
|||||
|
2022
Q3 | $64.8M | Buy |
|
|||||
|
2022
Q2 | $54.9M | Buy |
|
|||||
|
2022
Q1 | $47.9M | Buy |
|
|||||
|
2021
Q4 | $37.6M | Sell |
|
|||||
|
2021
Q3 | $69.5M | Buy |
|
|||||
|
2021
Q2 | $40.1M | Buy |
|
|||||
|
2021
Q1 | $52M | Sell |
|
|||||
|
2020
Q4 | $71.1M | Buy |
|
|||||
|
2020
Q3 | $50.9M | Buy |
|
|||||
|
2020
Q2 | $44.2M | Buy |
|
|||||
|
2020
Q1 | $37.5M | Buy |
|
|||||
|
2019
Q4 | $3.47M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.73M | Sell |
|
|||||
|
2018
Q1 | $1.46M | Buy |
|
|||||
|
2017
Q4 | $12K | Sell |
|
|||||
|
2017
Q3 | $11K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $8.94M | Sell |
|
|||||
|
2013
Q2 | $13.6M | Buy |
|